EdgarLookup
SC 13G/A

AMENDMENT NO. 1 TO SCHEDULE 13G

Company
4D Molecular Therapeutics, Inc.
Filed
June 21, 2022
Accession Number
0000921895-22-002049
View Document ↗ View on SEC.gov ↗